MedTrace Logo

Multimodal Neuromodulation in Individuals With Parkinson's Disease

NCT05105776 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2024-05-29

No results posted yet for this study

Summary

Multimodal non-invasive neuromodulation paired with physical therapy is a promising treatment modality for Parkinson's Disease ("PD"), however the optimal stimulation method, dose, and associated therapeutic protocol for long-lasting clinical benefits have not yet been identified for this population.

Here the investigators aim to develop and execute a preliminary clinical study exploring the potential benefits of multimodal non-invasive neuromodulation. The therapeutic intervention will involve translingual neurostimulation +/- galvanic neurostimulation, paired with an intensive physical and cognitive therapy program.

Conditions

  • Parkinson Disease

Interventions

DEVICE

Galvanic stimulation

Galvanic stimulation during physiotherapy sessions

Sponsors & Collaborators

  • Pacific Parkinson's Research Institute

    collaborator UNKNOWN

  • University of British Columbia

    collaborator OTHER

  • Ryan D'Arcy

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-09
Primary Completion
2024-05-02
Completion
2024-05-02

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05105776 on ClinicalTrials.gov